Watch the health video

If the player does not load, watch this video on YouTube.

Channel: i3 Health

Uploaded: October 16, 2026, 3:03:03 PM UTC

About this video

Over 50% response rate and near-universal tumor reduction—here is the clinical data on pimicotinib! In the MANEUVER study, the oral CSF-1R inhibitor pimicotinib achieved a 54% response rate by RECIST, an excess of 60% reduction in tumor vol

This summary reflects the source description published by i3 Health; it is not an independent medical review.

Health information note

This page shares a video and a brief description-based summary for general information. It is not a diagnosis or personal medical advice. For questions about your own health, consult a qualified healthcare professional; seek urgent local medical care for emergencies.

✳
Keep your curiosity going.

Good information should help you ask better questions, not stop asking them.

FILED UNDERhealth and wellnesshealth videohealth educationcancer awareness and screeningi3 HealthPages Alerts